Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de abr de 2001
ID: NCT00146328
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Active-Controlled, Staged, Open-Label Trial to Investigate Safety and Efficacy of BMS-955176/GSK3532795 in Combination With Dolutegravir and Atazanavir (With or Without Ritonavir) in Treatment-Experienced HIV-1 Infected Adults
INTERVENTIONAL
Inicio: 8 de jul de 2015
ID: NCT02386098
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Phase II Study to Evaluate the Safety, Tolerance and Efficacy of Multiple Doses of SCH 56592 Versus Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
INTERVENTIONAL
ID: NCT00002399
Completado
ClinicalTrials.gov
"Multicenter Observational Study to Assess the Incidence and Features of COVID-19 and the Response to COVID-19 Vaccination in Fragile Patients"
OBSERVATIONAL
Inicio: 24 de may de 2021
ID: NCT05222139
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a, Randomized, Active-Comparator-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Individuals With Nonalcoholic Fatty Liver Disease
INTERVENTIONAL
Inicio: 4 de ago de 2021
ID: NCT04944992
Completado
Fase 3
ClinicalTrials.gov
Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)
INTERVENTIONAL
Inicio: 19 de ago de 2020
ID: NCT04518410
Completado
ClinicalTrials.gov
Biomarker Study to Identify Subjects With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
OBSERVATIONAL
Inicio: 1 de ago de 2019
ID: NCT03955913
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIB, Randomized, Controlled, Observer-blind Study to Evaluate Safety and Immunogenicity of GSK's Meningococcal ABCWY Vaccine When Administered in Healthy Adolescents and Adults, Previously Primed With Meningococcal ACWY Vaccine
INTERVENTIONAL
Inicio: 25 de ene de 2021
ID: NCT04707391
Completado
Fase 3
ClinicalTrials.gov
Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00395018
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin and Skin Structure Infection
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00424190
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis
INTERVENTIONAL
Inicio: 11 de sept de 2018
ID: NCT03517540
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-dummy, Double-blind, Multicenter Trial Comparing the Safety and Efficacy of Intravenous Moxifloxacin 400 mg IV QD 24 Hours to That of Ertapenem 1.0 g IV QD 24 Hours for 5 to 14 Days for the Treatment of Subjects With Complicated Intra-abdominal Infections (PROMISE Study)
INTERVENTIONAL
Inicio: 1 de jul de 2006
ID: NCT00492726
Completado
Fase 4
ClinicalTrials.gov
A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety of Atazanavir (ATV) Capsule Boosted With Ritonavir (RTV) With an Optimized NRTI Background Therapy, in HIV Infected, Antiretroviral Naive and Experienced Pediatric Subjects Greater Than or Equal to 6 Years to Less Than 18 Years
INTERVENTIONAL
Inicio: 30 de nov de 2012
ID: NCT01691794
Completado
Fase 3
ClinicalTrials.gov
INHALEd Unfractionated HEParin for the Treatment of Hospitalised Patients With COVID-19 Meta-trial
INTERVENTIONAL
Inicio: 1 de jun de 2020
ID: NCT04635241
Desconocido
ClinicalTrials.gov
VENOUS: A Translational Study of Enterococcal Bacteremia
OBSERVATIONAL
Inicio: 1 de ago de 2016
ID: NCT04410276
Completado
Fase 2
ClinicalTrials.gov
A Phase II/III 48-Week, Randomized, Double-Blind, Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lamivudine 300mg Once Daily Vs. Lamivudine 150mg BID in Combination With Zidovudine 300mg BID and Efavirenz 600mg Once Daily in Antiretroviral-Naive Adults With HIV-1 Infection
INTERVENTIONAL
Inicio: 1 de sept de 1999
ID: NCT00004852
Terminado
ClinicalTrials.gov
AO Multicenter Intervention Trial to Evaluate the Impact of a Bundle of Measures for the Prevention of Surgical Site Infection in Fracture Patients
INTERVENTIONAL
Inicio: 6 de dic de 2019
ID: NCT03380273
Completado
Fase 4
ClinicalTrials.gov
Randomized Controlled Trial of High Dose of Vitamin D as Compared With Placebo to Prevent Complications Among COVID-19 Patients
INTERVENTIONAL
Inicio: 11 de ago de 2020
ID: NCT04411446
Completado
ClinicalTrials.gov
An International Observational Study to Characterize Adults With Influenza or Other Targeted Respiratory Viruses
OBSERVATIONAL
Inicio: 1 de ago de 2009
ID: NCT01056354
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIa, Randomized, Double-blind, Active-controlled, 12-week Study of Amdoxovir (Two Doses) Versus Tenofovir DF, in Combination With Zidovudine in HIV-1 Treatment-experienced Subjects With M184I/V Mutation in Addition to 0-2 Confirmed Thymidine Analog Mutations.
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01737359
Anterior
1
...
27
28
29
...
434
Siguiente
Filtros